Development of Minimally Invasive Cancer Immunotherapy Using Anti-Disialoganglioside GD2 Antibody-Producing Mesenchymal Stem Cells for a Neuroblastoma Mouse Model

Mouse IgG anti-disialoganglioside GD2 antibody-secreting mouse mesenchymal stem cells were developed, and their anti-tumor effects were validated in an in vivo neuroblastoma mouse model.